Review




Structured Review

Novocastra ihc for p53
Ihc For P53, supplied by Novocastra, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ihc+for+p53/anti+p53/pm42128055-102-22-27
Average 86 stars, based on 1 article reviews
ihc for p53 - by Bioz Stars, 2026-09
86/100 stars

Images

Related Articles

Biomarker Discovery:

Article Title: Intraductal Papillary Squamous Neoplasm (IPSN) of the Pancreas: Histologic and Molecular Characterization of a Novel and Distinct Intraductal Cancer Precursor.
Article Snippet: .. Validation IHC and fluorescence in situ hybridization (FISH) As an additional validation of DNA sequencing, all distinct tumor regions were evaluated with IHC for P53 (DO-7, prediluted, Novocastra), DPC4/SMAD4 (B-8, 1:500, Santa Cruz), INI- Jo ur na l P r -p ro of 1/SMARCB1 (BAF47, prediluted, BD, USA), BRG-1/SMARCA4 (BSB-154, prediluted, BIO-SB, USA), MLH1 (ES05; prediluted, Leica), PMS2 (EP51; prediluted, Leica), MSH2 (79H11; prediluted, Leica), and MSH6 (EP49; prediluted, Leica). .. Alterations of CDKN2A were further investigated by fluorescence in situ hybridization (FISH) using a commercially available probe (ZytoLight, CDKN2A/CEN 9, ZytoVision, Germany) designed to detect CDKN2A deletions (chromosomal region 9p21.3).

Immunohistochemistry:

Article Title: Intraductal Papillary Squamous Neoplasm (IPSN) of the Pancreas: Histologic and Molecular Characterization of a Novel and Distinct Intraductal Cancer Precursor.
Article Snippet: .. Validation IHC and fluorescence in situ hybridization (FISH) As an additional validation of DNA sequencing, all distinct tumor regions were evaluated with IHC for P53 (DO-7, prediluted, Novocastra), DPC4/SMAD4 (B-8, 1:500, Santa Cruz), INI- Jo ur na l P r -p ro of 1/SMARCB1 (BAF47, prediluted, BD, USA), BRG-1/SMARCA4 (BSB-154, prediluted, BIO-SB, USA), MLH1 (ES05; prediluted, Leica), PMS2 (EP51; prediluted, Leica), MSH2 (79H11; prediluted, Leica), and MSH6 (EP49; prediluted, Leica). .. Alterations of CDKN2A were further investigated by fluorescence in situ hybridization (FISH) using a commercially available probe (ZytoLight, CDKN2A/CEN 9, ZytoVision, Germany) designed to detect CDKN2A deletions (chromosomal region 9p21.3).

Article Title: A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma
Article Snippet: Fluorescence in situ hybridization for TP53 was performed using the Vysis LSI TP53/CEP 17 FISH probe kit (Abbott Molecular) following standard protocols. .. IHC for p53 (dilution 1:100, clone D07; Novocastra) was performed on FFPE archival blocks following standard protocols using a Ventana automatic immunostainer (Ventana, Benchmark). ..

Fluorescence:

Article Title: Intraductal Papillary Squamous Neoplasm (IPSN) of the Pancreas: Histologic and Molecular Characterization of a Novel and Distinct Intraductal Cancer Precursor.
Article Snippet: .. Validation IHC and fluorescence in situ hybridization (FISH) As an additional validation of DNA sequencing, all distinct tumor regions were evaluated with IHC for P53 (DO-7, prediluted, Novocastra), DPC4/SMAD4 (B-8, 1:500, Santa Cruz), INI- Jo ur na l P r -p ro of 1/SMARCB1 (BAF47, prediluted, BD, USA), BRG-1/SMARCA4 (BSB-154, prediluted, BIO-SB, USA), MLH1 (ES05; prediluted, Leica), PMS2 (EP51; prediluted, Leica), MSH2 (79H11; prediluted, Leica), and MSH6 (EP49; prediluted, Leica). .. Alterations of CDKN2A were further investigated by fluorescence in situ hybridization (FISH) using a commercially available probe (ZytoLight, CDKN2A/CEN 9, ZytoVision, Germany) designed to detect CDKN2A deletions (chromosomal region 9p21.3).

In Situ Hybridization:

Article Title: Intraductal Papillary Squamous Neoplasm (IPSN) of the Pancreas: Histologic and Molecular Characterization of a Novel and Distinct Intraductal Cancer Precursor.
Article Snippet: .. Validation IHC and fluorescence in situ hybridization (FISH) As an additional validation of DNA sequencing, all distinct tumor regions were evaluated with IHC for P53 (DO-7, prediluted, Novocastra), DPC4/SMAD4 (B-8, 1:500, Santa Cruz), INI- Jo ur na l P r -p ro of 1/SMARCB1 (BAF47, prediluted, BD, USA), BRG-1/SMARCA4 (BSB-154, prediluted, BIO-SB, USA), MLH1 (ES05; prediluted, Leica), PMS2 (EP51; prediluted, Leica), MSH2 (79H11; prediluted, Leica), and MSH6 (EP49; prediluted, Leica). .. Alterations of CDKN2A were further investigated by fluorescence in situ hybridization (FISH) using a commercially available probe (ZytoLight, CDKN2A/CEN 9, ZytoVision, Germany) designed to detect CDKN2A deletions (chromosomal region 9p21.3).

Fluorescence In Situ Hybridization:

Article Title: Intraductal Papillary Squamous Neoplasm (IPSN) of the Pancreas: Histologic and Molecular Characterization of a Novel and Distinct Intraductal Cancer Precursor.
Article Snippet: .. Validation IHC and fluorescence in situ hybridization (FISH) As an additional validation of DNA sequencing, all distinct tumor regions were evaluated with IHC for P53 (DO-7, prediluted, Novocastra), DPC4/SMAD4 (B-8, 1:500, Santa Cruz), INI- Jo ur na l P r -p ro of 1/SMARCB1 (BAF47, prediluted, BD, USA), BRG-1/SMARCA4 (BSB-154, prediluted, BIO-SB, USA), MLH1 (ES05; prediluted, Leica), PMS2 (EP51; prediluted, Leica), MSH2 (79H11; prediluted, Leica), and MSH6 (EP49; prediluted, Leica). .. Alterations of CDKN2A were further investigated by fluorescence in situ hybridization (FISH) using a commercially available probe (ZytoLight, CDKN2A/CEN 9, ZytoVision, Germany) designed to detect CDKN2A deletions (chromosomal region 9p21.3).

DNA Sequencing:

Article Title: Intraductal Papillary Squamous Neoplasm (IPSN) of the Pancreas: Histologic and Molecular Characterization of a Novel and Distinct Intraductal Cancer Precursor.
Article Snippet: .. Validation IHC and fluorescence in situ hybridization (FISH) As an additional validation of DNA sequencing, all distinct tumor regions were evaluated with IHC for P53 (DO-7, prediluted, Novocastra), DPC4/SMAD4 (B-8, 1:500, Santa Cruz), INI- Jo ur na l P r -p ro of 1/SMARCB1 (BAF47, prediluted, BD, USA), BRG-1/SMARCA4 (BSB-154, prediluted, BIO-SB, USA), MLH1 (ES05; prediluted, Leica), PMS2 (EP51; prediluted, Leica), MSH2 (79H11; prediluted, Leica), and MSH6 (EP49; prediluted, Leica). .. Alterations of CDKN2A were further investigated by fluorescence in situ hybridization (FISH) using a commercially available probe (ZytoLight, CDKN2A/CEN 9, ZytoVision, Germany) designed to detect CDKN2A deletions (chromosomal region 9p21.3).

Formalin-fixed Paraffin-Embedded:

Article Title: A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma
Article Snippet: Fluorescence in situ hybridization for TP53 was performed using the Vysis LSI TP53/CEP 17 FISH probe kit (Abbott Molecular) following standard protocols. .. IHC for p53 (dilution 1:100, clone D07; Novocastra) was performed on FFPE archival blocks following standard protocols using a Ventana automatic immunostainer (Ventana, Benchmark). ..



Similar Products

86
Novocastra ihc for p53
Ihc For P53, supplied by Novocastra, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ihc+for+p53/anti+p53/pm42128055-102-22-27
Average 86 stars, based on 1 article reviews
ihc for p53 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

86
Wolters Kluwer Health p53 ihc assays
P53 Ihc Assays, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ihc+for+p53/p53/10__1097_slash_pai__0000000000001314-100-15-2
Average 86 stars, based on 1 article reviews
p53 ihc assays - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

90
Cell Marque p53 ihc cell marque do-7
P53 Ihc Cell Marque Do 7, supplied by Cell Marque, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ihc+for+p53/p53+ihc+cell+marque+do+7/pm40528003-137-1-3
Average 90 stars, based on 1 article reviews
p53 ihc cell marque do-7 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

96
Proteintech p53 proteintech 10442 1 ap wb ihc
P53 Proteintech 10442 1 Ap Wb Ihc, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ihc+for+p53/P53+Antibody/pmc12141605__42003_2025_8296_MOESM1_ESM-26-11-12
Average 96 stars, based on 1 article reviews
p53 proteintech 10442 1 ap wb ihc - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

90
Human Protein Atlas ihc analyses of p53 and vegfa expression
Ihc Analyses Of P53 And Vegfa Expression, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ihc+for+p53/ihc+analyses+of+p53+and+vegfa+expression/10__1021_slash_acsomega__5c01334-74-6-9
Average 90 stars, based on 1 article reviews
ihc analyses of p53 and vegfa expression - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Human Protein Atlas ihc analyses p53
Upregulation of <t>p53</t> and VEGFA in human cancers. (A,B) Comparison of p53 ( n = 443) or VEGFA ( n = 452) expression in different types of cancer analyzed by Oncomine. (C,D) p53 and VEGFA expression in different primary tumors and corresponding normal tissues analyzed by Metabolic gEne RApid Visualizer. (E,F) p53 and VEGFA expression in normal brain tissue and corresponding glioblastoma tissue as revealed by IHC from Human Protein Atlas. (G,H) Survival probability analyses of p53 and VEGFA expression by Kaplan–Meier plotter ( n = 153).
Ihc Analyses P53, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ihc+for+p53/ihc+analyses+p53/pmc12177586-49-4-9
Average 90 stars, based on 1 article reviews
ihc analyses p53 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc ihc 200 p53 7f5 2527s cell signaling wb
Upregulation of <t>p53</t> and VEGFA in human cancers. (A,B) Comparison of p53 ( n = 443) or VEGFA ( n = 452) expression in different types of cancer analyzed by Oncomine. (C,D) p53 and VEGFA expression in different primary tumors and corresponding normal tissues analyzed by Metabolic gEne RApid Visualizer. (E,F) p53 and VEGFA expression in normal brain tissue and corresponding glioblastoma tissue as revealed by IHC from Human Protein Atlas. (G,H) Survival probability analyses of p53 and VEGFA expression by Kaplan–Meier plotter ( n = 153).
Ihc 200 P53 7f5 2527s Cell Signaling Wb, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ihc+for+p53/p53+Rabbit+mAb/pmc11894096__41467_2025_57539_MOESM1_ESM-84-42-47
Average 96 stars, based on 1 article reviews
ihc 200 p53 7f5 2527s cell signaling wb - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology ihc staining
Upregulation of <t>p53</t> and VEGFA in human cancers. (A,B) Comparison of p53 ( n = 443) or VEGFA ( n = 452) expression in different types of cancer analyzed by Oncomine. (C,D) p53 and VEGFA expression in different primary tumors and corresponding normal tissues analyzed by Metabolic gEne RApid Visualizer. (E,F) p53 and VEGFA expression in normal brain tissue and corresponding glioblastoma tissue as revealed by IHC from Human Protein Atlas. (G,H) Survival probability analyses of p53 and VEGFA expression by Kaplan–Meier plotter ( n = 153).
Ihc Staining, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ihc+for+p53/p53/pm39971971-432-1-12
Average 96 stars, based on 1 article reviews
ihc staining - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology ihc santa cruz
Upregulation of <t>p53</t> and VEGFA in human cancers. (A,B) Comparison of p53 ( n = 443) or VEGFA ( n = 452) expression in different types of cancer analyzed by Oncomine. (C,D) p53 and VEGFA expression in different primary tumors and corresponding normal tissues analyzed by Metabolic gEne RApid Visualizer. (E,F) p53 and VEGFA expression in normal brain tissue and corresponding glioblastoma tissue as revealed by IHC from Human Protein Atlas. (G,H) Survival probability analyses of p53 and VEGFA expression by Kaplan–Meier plotter ( n = 153).
Ihc Santa Cruz, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ihc+for+p53/p53+Antibody/pm39824446-211-93-94
Average 96 stars, based on 1 article reviews
ihc santa cruz - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

Image Search Results


Upregulation of p53 and VEGFA in human cancers. (A,B) Comparison of p53 ( n = 443) or VEGFA ( n = 452) expression in different types of cancer analyzed by Oncomine. (C,D) p53 and VEGFA expression in different primary tumors and corresponding normal tissues analyzed by Metabolic gEne RApid Visualizer. (E,F) p53 and VEGFA expression in normal brain tissue and corresponding glioblastoma tissue as revealed by IHC from Human Protein Atlas. (G,H) Survival probability analyses of p53 and VEGFA expression by Kaplan–Meier plotter ( n = 153).

Journal: ACS Omega

Article Title: Identification of a Natural Small Molecule Dauricine for Glioma Therapy through Targeting p53 and VEGFA Pathways

doi: 10.1021/acsomega.5c01334

Figure Lengend Snippet: Upregulation of p53 and VEGFA in human cancers. (A,B) Comparison of p53 ( n = 443) or VEGFA ( n = 452) expression in different types of cancer analyzed by Oncomine. (C,D) p53 and VEGFA expression in different primary tumors and corresponding normal tissues analyzed by Metabolic gEne RApid Visualizer. (E,F) p53 and VEGFA expression in normal brain tissue and corresponding glioblastoma tissue as revealed by IHC from Human Protein Atlas. (G,H) Survival probability analyses of p53 and VEGFA expression by Kaplan–Meier plotter ( n = 153).

Article Snippet: Furthermore, IHC analyses of p53 and VEGFA expression from Human Protein Atlas ( https://www.proteinatlas.org/ ) also indicated that both p53 and VEGFA were upregulated in gliomas ( E,F).

Techniques: Comparison, Expressing

Molecular docking of dauricine and the p53 core domain as well as VEGFA. (A) Dauricine binds to the L1/S3 pocket of p53, forming two hydrogen bonds with Gln144 and Pro142 from Sheet3. P53 is shown in blue, and dauricine in yellow. The hydrogen bonds are shown with gray dashed lines. The rest part of the dauricine is hidden for the clarity of view. (B) Dauricine interacts with Ser116, Cys124, and Thr140 in the L1/S3 pocket of p53. (C) Dauricine binds to the L1/L3 region of VEGFA, interacting with Phe36 and Ile46 in the Loop1 (L1) region. (D) Dauricine binds to the Loop3 (L3) region of VEGFA, forming a hydrogen bond with His86 and interacting with Lys84 as well as Pro85.

Journal: ACS Omega

Article Title: Identification of a Natural Small Molecule Dauricine for Glioma Therapy through Targeting p53 and VEGFA Pathways

doi: 10.1021/acsomega.5c01334

Figure Lengend Snippet: Molecular docking of dauricine and the p53 core domain as well as VEGFA. (A) Dauricine binds to the L1/S3 pocket of p53, forming two hydrogen bonds with Gln144 and Pro142 from Sheet3. P53 is shown in blue, and dauricine in yellow. The hydrogen bonds are shown with gray dashed lines. The rest part of the dauricine is hidden for the clarity of view. (B) Dauricine interacts with Ser116, Cys124, and Thr140 in the L1/S3 pocket of p53. (C) Dauricine binds to the L1/L3 region of VEGFA, interacting with Phe36 and Ile46 in the Loop1 (L1) region. (D) Dauricine binds to the Loop3 (L3) region of VEGFA, forming a hydrogen bond with His86 and interacting with Lys84 as well as Pro85.

Article Snippet: Furthermore, IHC analyses of p53 and VEGFA expression from Human Protein Atlas ( https://www.proteinatlas.org/ ) also indicated that both p53 and VEGFA were upregulated in gliomas ( E,F).

Techniques:

Dauricine upregulates p53 expression, downregulates VEGFA expression, and induces apoptosis in glioma cells. (A) Western blot analyses of p53 and its downstream genes. (B) Gray scale statistics of protein expression in U87 cells. (C) Western blot analyses of VEGFA and its downstream genes. (D, E) Gray scale statistics of protein expression in C6 cells (* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001 vs control, n = 3).

Journal: ACS Omega

Article Title: Identification of a Natural Small Molecule Dauricine for Glioma Therapy through Targeting p53 and VEGFA Pathways

doi: 10.1021/acsomega.5c01334

Figure Lengend Snippet: Dauricine upregulates p53 expression, downregulates VEGFA expression, and induces apoptosis in glioma cells. (A) Western blot analyses of p53 and its downstream genes. (B) Gray scale statistics of protein expression in U87 cells. (C) Western blot analyses of VEGFA and its downstream genes. (D, E) Gray scale statistics of protein expression in C6 cells (* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001 vs control, n = 3).

Article Snippet: Furthermore, IHC analyses of p53 and VEGFA expression from Human Protein Atlas ( https://www.proteinatlas.org/ ) also indicated that both p53 and VEGFA were upregulated in gliomas ( E,F).

Techniques: Expressing, Western Blot, Control

Pathological analyses of C6 glioma xenograft tissue. (A) HE staining was performed on three groups of C6 tumor tissue sections. Photos were taken under the microscope at 100× and 400×. Blue-violet staining indicates tumor cell nuclei. (B) IHC analyses of the tumor sections. p53 and VEGFA were detected in the subcutaneous xenograft tumor sections of nude mice. Brown staining indicates positive signals. (C,D) Statistical analyses of p53 and VEGFA expression in IHC staining of the xenograft (* P < 0.05, ** P < 0.01, **** P < 0.0001 vs Control, n = 6).

Journal: ACS Omega

Article Title: Identification of a Natural Small Molecule Dauricine for Glioma Therapy through Targeting p53 and VEGFA Pathways

doi: 10.1021/acsomega.5c01334

Figure Lengend Snippet: Pathological analyses of C6 glioma xenograft tissue. (A) HE staining was performed on three groups of C6 tumor tissue sections. Photos were taken under the microscope at 100× and 400×. Blue-violet staining indicates tumor cell nuclei. (B) IHC analyses of the tumor sections. p53 and VEGFA were detected in the subcutaneous xenograft tumor sections of nude mice. Brown staining indicates positive signals. (C,D) Statistical analyses of p53 and VEGFA expression in IHC staining of the xenograft (* P < 0.05, ** P < 0.01, **** P < 0.0001 vs Control, n = 6).

Article Snippet: Furthermore, IHC analyses of p53 and VEGFA expression from Human Protein Atlas ( https://www.proteinatlas.org/ ) also indicated that both p53 and VEGFA were upregulated in gliomas ( E,F).

Techniques: Staining, Microscopy, Expressing, Immunohistochemistry, Control